As of 2026-03-31, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -7.82 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 30.28 USD, the upside of Edgewise Therapeutics Inc is -125.83%.
Based on its market price of 30.28 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 125.83%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.82 - -7.82 | -7.82 | -125.83% |
| P/E | (28.41) - (31.44) | (29.64) | -197.9% |
| DDM - Stable | (15.36) - (47.92) | (31.64) | -204.5% |
| DDM - Multi | (0.24) - (0.56) | (0.33) | -101.1% |
| Market Cap (mil) | 3,248.14 |
| Beta | 2.13 |
| Outstanding shares (mil) | 107.27 |
| Enterprise Value (mil) | 3,186.99 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.03% |
| Cost of Debt | 5.00% |
| WACC | 6.46% |